Renal bioengineering with scaffolds generated from rat and pig kidneys.

Nephron Experimental Nephrology Pub Date : 2014-01-01 Epub Date: 2014-05-19 DOI:10.1159/000360683
Marina Figliuzzi, Giuseppe Remuzzi, Andrea Remuzzi
{"title":"Renal bioengineering with scaffolds generated from rat and pig kidneys.","authors":"Marina Figliuzzi,&nbsp;Giuseppe Remuzzi,&nbsp;Andrea Remuzzi","doi":"10.1159/000360683","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic kidney disease (CKD) is a global public health issue with an estimated prevalence of 8-16% worldwide. End-stage renal disease eventually develops every year in 0.15-0.2% of patients with overt CKD, and renal replacement therapy (RRT) with dialysis or transplantation is required. Although approximately 2 million people worldwide are currently on RRT to sustain life, this likely represents less than 10% of those who need it. The kidney transplant approach is also seriously impaired by limited graft survival and by the scarce availability of donors. Innovative tissue-engineering strategies have been recently proposed to overcome these challenges. It is anticipated that these novel approaches will also be cost-effective in the long term. Although the initial setup of these innovative technologies could be quite expensive, there would be a single application for each patient, with no additional costs thereafter, compared to the lifelong costs of dialysis or immunosuppressive medications required for transplantation. One of the most innovative tools currently being investigated in experimental models is based on the idea of using decellularized kidneys to engineer a new functional organ as a potential future treatment option for end-stage renal disease.</p><p><strong>Summary: </strong>In the last 5 years, several interesting observations have been reported regarding the possibility of using an acellular matrix from the whole kidney and the attempt to recellularize this scaffold using stem or differentiated cells. This review provides an overview of the decellularization methods tested so far and their effects on the resulting extracellular matrix structure and composition. In addition, we also discuss methods recently described by us and others for the perfusion of kidney scaffolds for recellularization.</p><p><strong>Key messages: </strong>Despite difficulties in achieving the import goal of kidney engineering in the laboratory, we discuss the problems with and limits of the experimental results obtained so far and point out the strategies that need to be adopted in order for this line of research to advance.</p>","PeriodicalId":18993,"journal":{"name":"Nephron Experimental Nephrology","volume":"126 2","pages":"113"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000360683","citationCount":"20","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephron Experimental Nephrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000360683","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/5/19 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 20

Abstract

Background: Chronic kidney disease (CKD) is a global public health issue with an estimated prevalence of 8-16% worldwide. End-stage renal disease eventually develops every year in 0.15-0.2% of patients with overt CKD, and renal replacement therapy (RRT) with dialysis or transplantation is required. Although approximately 2 million people worldwide are currently on RRT to sustain life, this likely represents less than 10% of those who need it. The kidney transplant approach is also seriously impaired by limited graft survival and by the scarce availability of donors. Innovative tissue-engineering strategies have been recently proposed to overcome these challenges. It is anticipated that these novel approaches will also be cost-effective in the long term. Although the initial setup of these innovative technologies could be quite expensive, there would be a single application for each patient, with no additional costs thereafter, compared to the lifelong costs of dialysis or immunosuppressive medications required for transplantation. One of the most innovative tools currently being investigated in experimental models is based on the idea of using decellularized kidneys to engineer a new functional organ as a potential future treatment option for end-stage renal disease.

Summary: In the last 5 years, several interesting observations have been reported regarding the possibility of using an acellular matrix from the whole kidney and the attempt to recellularize this scaffold using stem or differentiated cells. This review provides an overview of the decellularization methods tested so far and their effects on the resulting extracellular matrix structure and composition. In addition, we also discuss methods recently described by us and others for the perfusion of kidney scaffolds for recellularization.

Key messages: Despite difficulties in achieving the import goal of kidney engineering in the laboratory, we discuss the problems with and limits of the experimental results obtained so far and point out the strategies that need to be adopted in order for this line of research to advance.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
以大鼠和猪肾脏为支架的肾脏生物工程。
背景:慢性肾脏疾病(CKD)是一个全球性的公共卫生问题,估计全球患病率为8-16%。每年有0.15-0.2%的显性CKD患者最终发展为终末期肾病,需要透析或移植的肾脏替代治疗(RRT)。尽管目前全世界约有200万人正在通过RRT来维持生命,但这可能只占需要RRT的人数的不到10%。肾移植方法也受到移植物存活有限和供体稀缺的严重损害。最近提出了创新的组织工程策略来克服这些挑战。预计从长远来看,这些新方法也将具有成本效益。虽然这些创新技术的初始设置可能相当昂贵,但与移植所需的透析或免疫抑制药物的终身费用相比,每个患者只需一次应用,此后没有额外费用。目前在实验模型中研究的最具创新性的工具之一是基于使用脱细胞肾脏来设计新的功能器官的想法,作为终末期肾脏疾病的潜在未来治疗选择。摘要:在过去的5年里,关于使用全肾脱细胞基质的可能性,以及使用干细胞或分化细胞将这种支架再细胞化的尝试,已经报道了一些有趣的观察结果。本文综述了迄今为止测试的脱细胞方法及其对细胞外基质结构和组成的影响。此外,我们还讨论了我们和其他人最近描述的肾支架灌注再细胞化的方法。关键信息:尽管在实验室中实现肾脏工程的重要目标存在困难,但我们讨论了迄今为止获得的实验结果的问题和局限性,并指出了为了推进这一研究方向需要采取的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Nephron Experimental Nephrology
Nephron Experimental Nephrology 医学-泌尿学与肾脏学
自引率
0.00%
发文量
0
审稿时长
>12 weeks
期刊最新文献
Inhalation of Hydrogen Gas Is Beneficial for Preventing Contrast-Induced Acute Kidney Injury in Rats. Contents Vol. 128, 2014 Stimulation of Cyclooxygenase 2 Expression in Rat Peritoneal Mesothelial Cells. Polyuria in Hantavirus Infection Reflects Disease Severity and Is Associated with Prolonged Hospital Stay: A Systematic Analysis of 335 Patients from Southern Germany. Beneficial Effects of AMP-Activated Protein Kinase Agonists in Kidney Ischemia-Reperfusion: Autophagy and Cellular Stress Markers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1